Norden Group LLC Grows Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Norden Group LLC lifted its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 14,465 shares of the company’s stock after purchasing an additional 700 shares during the quarter. Norden Group LLC’s holdings in Prestige Consumer Healthcare were worth $1,130,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Smartleaf Asset Management LLC boosted its holdings in Prestige Consumer Healthcare by 29.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 4,237 shares of the company’s stock worth $328,000 after acquiring an additional 964 shares during the period. Bridges Investment Management Inc. acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $213,000. QRG Capital Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 3.3% in the fourth quarter. QRG Capital Management Inc. now owns 5,496 shares of the company’s stock valued at $429,000 after purchasing an additional 176 shares during the period. Proficio Capital Partners LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter valued at $1,689,000. Finally, Handelsbanken Fonder AB increased its stake in Prestige Consumer Healthcare by 7.6% during the 4th quarter. Handelsbanken Fonder AB now owns 15,581 shares of the company’s stock worth $1,217,000 after buying an additional 1,100 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 1.0 %

NYSE:PBH opened at $84.61 on Monday. The company has a market cap of $4.19 billion, a PE ratio of 19.81, a P/E/G ratio of 2.69 and a beta of 0.50. The business’s 50 day moving average is $80.04 and its two-hundred day moving average is $77.28. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on PBH. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a report on Monday, December 9th. DA Davidson increased their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Finally, Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.60.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.